These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1129 related articles for article (PubMed ID: 35522946)

  • 21. N
    Hill RA; Liu YY
    Clin Transl Med; 2022 May; 12(5):e889. PubMed ID: 35604883
    [No Abstract]   [Full Text] [Related]  

  • 22. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W; Xiao G; Xie G; Chen Z; Xu X; Zeng J; Xie J
    Thorac Cancer; 2024 Sep; 15(26):1871-1881. PubMed ID: 39090761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis.
    Yao F; Zhao Y; Wang G; Zhao M; Hong X; Ye Z; Dong F; Li W; Deng Q
    Cell Signal; 2024 Aug; 120():111221. PubMed ID: 38729321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
    Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
    Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3-driven m6A modification of lncRNA FAM230B suppresses ferroptosis by modulating miR-27a-5p/BTF3 axis in gastric cancer.
    Cui Y; Pu M; Gong Y; Li R; Wang X; Ye J; Huang H; Liao D; Yang Y; Yin A; Li J; Deng Y; Tian Z; Pu R
    Biochim Biophys Acta Gen Subj; 2024 Nov; 1868(11):130714. PubMed ID: 39278369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma.
    Wang J; Xiu M; Wang J; Gao Y; Li Y
    J Hematol Oncol; 2024 Sep; 17(1):78. PubMed ID: 39218945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4.
    Meng X; Wang Z; Yang Q; Liu Y; Gao Y; Chen H; Li A; Li R; Wang J; Sun G
    Cell Death Dis; 2024 Oct; 15(10):729. PubMed ID: 39368999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1.
    Song D; Wang Q; Yan Z; Su M; Zhang H; Shi L; Fan Y; Zhang Q; Yang H; Zhang D; Liu Q
    Biol Direct; 2024 Jun; 19(1):44. PubMed ID: 38849910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. METTL14 plays an oncogenic role in NSCLC by modulating ferroptosis and the m6A modification of GPX4.
    Lou Y; Huang K; Xu B; Chen X
    Arch Physiol Biochem; 2024 Dec; 130(6):962-973. PubMed ID: 38993012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.
    Dong G; Yu J; Shan G; Su L; Yu N; Yang S
    Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIF-1α-induced upregulation of m6A reader IGF2BP1 facilitates peripheral nerve injury recovery by enhancing SLC7A11 mRNA stabilization.
    An S; Shi J; Huang J; Li Z; Feng M; Cao G
    In Vitro Cell Dev Biol Anim; 2023 Sep; 59(8):596-605. PubMed ID: 37783915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
    J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATF1 promotes ferroptosis resistance in lung cancer through enhancing mRNA stability of PROM2.
    Hu M; Yang J; Tan Z
    Exp Cell Res; 2024 Sep; 442(1):114190. PubMed ID: 39098467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
    Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
    J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m
    Sun S; Gao T; Pang B; Su X; Guo C; Zhang R; Pang Q
    Cell Death Dis; 2022 Jan; 13(1):73. PubMed ID: 35064112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma.
    Dong FL; Xu ZZ; Wang YQ; Li T; Wang X; Li J
    J Nanobiotechnology; 2024 May; 22(1):298. PubMed ID: 38811968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m
    Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
    Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
    [No Abstract]   [Full Text] [Related]  

  • 40. KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m
    Wang H; Chen W; Cui Y; Gong H; Li H
    J Cell Mol Med; 2023 Dec; 27(24):4118-4132. PubMed ID: 37830241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.